Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 5:18 AM
Ignite Modification Date: 2025-12-26 @ 4:26 AM
NCT ID: NCT03241927
Description: there was only one person in this study. No participants in Healthy Control arm.
Frequency Threshold: 0
Time Frame: 18 weeks
Study: NCT03241927
Study Brief: Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Pembrolizumab 200 mg IV infusion every 3 weeks Pembrolizumab: Day 1 of each 3 week cycle 0 None 0 1 1 1 View
Healthy Control Healthy Participants 0 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Bilateral Leg Edema SYSTEMATIC_ASSESSMENT General disorders None View
Tumor Pain SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) None View
Anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Creatinine Increased SYSTEMATIC_ASSESSMENT Investigations None View
Hair thinning SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Hyperuricemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders None View
Pneumonitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View